The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias.

Mellentin JD, Murre C, Donlon TA, McCaw PS, Smith SD, Carroll AJ, McDonald ME, Baltimore D, Cleary ML
Science. 1989 246 (4928): 379-82

PMID: 2799390 · DOI:10.1126/science.2799390

The gene (E2A) that codes for proteins with the properties of immunoglobulin enhancer binding factors E12/E47 was mapped to chromosome region 19p13.2-p13.3, a site associated with nonrandom translocations in acute lymphoblastic leukemias. The majority of t(1;19)(q23;p13)-carrying leukemias and cell lines studied contained rearrangements of E2A as determined by DNA blot analyses. The rearrangements altered the E2A transcriptional unit, resulting in the synthesis of a transcript larger than the normal-sized E2A mRNAs in one of the cell lines with this translocation. These observations indicate that the gene for a transcription factor is located at the breakpoint of a consistently recurring chromosomal translocation in many acute leukemias and suggest a direct role for alteration of such factors in the pathogenesis of some malignancies.

MeSH Terms (10)

Child Chromosome Mapping Chromosomes, Human, Pair 1 Chromosomes, Human, Pair 19 DNA-Binding Proteins Humans Precursor Cell Lymphoblastic Leukemia-Lymphoma Transcription Factors Translocation, Genetic Tumor Cells, Cultured

Connections (1)

This publication is referenced by other Labnodes entities: